ID
15304
Description
Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193973
Link
https://clinicaltrials.gov/show/NCT00193973
Keywords
Versions (1)
- 5/25/16 5/25/16 -
Uploaded on
May 25, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Primary Central Nervous System Lymphoma NCT00193973
Eligibility Primary Central Nervous System Lymphoma NCT00193973
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
history of malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
pregnant or lactating
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
nyha
Data type
boolean
Alias
- UMLS CUI [1]
- C1275491
Description
spinal thecal or spinal cord disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0037928
Similar models
Eligibility Primary Central Nervous System Lymphoma NCT00193973
- StudyEvent: Eligibility
C0857490 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0006147 (UMLS CUI [2])